名稱(chēng) | SIRPɑ Effector Reporter Cell |
型號(hào) | CBP74122 |
報(bào)價(jià) | ![]() |
特點(diǎn) | SIRPɑ Effector Reporter Cell,凍存條件:90% FBS+10% DMSO; |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- CD47/PD-(L)1 雙靶點(diǎn)細(xì)胞篩選模型簡(jiǎn)介
- 上海細(xì)胞庫(kù)——南京科佰生物
- TSLP靶點(diǎn)藥物細(xì)胞篩選模型
- 大腦中新發(fā)現(xiàn)的一種淋巴細(xì)胞,能夠清除大腦廢物
- 【現(xiàn)貨上線】HRR-Related-28 Gene標(biāo)準(zhǔn)品
- 靶向claudin18.2藥物細(xì)胞篩選模型
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- KIR3DL3/HHLA2細(xì)胞篩選模型
- IL-11藥物細(xì)胞模型簡(jiǎn)介
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74122SIRPɑ Effector Reporter Cell

- 詳細(xì)內(nèi)容
CBP74122 | |
I. Background | |
SIRP alpha protein, or Signal regulatory proteinalpha (SIRP-α), also known as Tyrosine protein phosphatase non-receptor type substrate 1, CD172a, Bit, and MyD-1, GenBank Accession No. NM_080792, a.a. 27-370, with C-terminal Avi and His tags, MW 40.3 kDa*. This SIRP alpha protein acts as a receptor for CD47; a.a. 27-370 correspond to the extracellular portion of SIRP-α. *Note: SIRP-α is heavily glycosylated, resulting in higher molecular weight. | |
II. Introduction | |
Expressed gene: | SIRPɑ |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | SIRP alpha protein, sirpa protein, sirp-a protein, SIRP?±, CD172a, Tyrosine-protein phosphatase non-receptor type substrate 1, CD172a, Bit, and MyD-1, 71138-1, 71138-2 |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+300ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Dose response of Sirpɑ Blocking Antibodies in SIRPɑ Effector Reporter Cells With CD47+ Target Cells. Figure 2. Dose response of CD47 Blocking Antibody in SIRPɑ Effector Reporter Cells(C11) With CD47+ Target Cells. | |